Date | Price Target | Rating | Analyst |
---|---|---|---|
7/9/2024 | $28.00 → $30.00 | Neutral → Buy | UBS |
6/7/2024 | $25.00 | Neutral | Mizuho |
4/9/2024 | $19.00 → $34.00 | Underperform → Outperform | BMO Capital Markets |
3/5/2024 | $37.00 → $21.00 | Buy → Neutral | UBS |
2/29/2024 | $45.00 → $19.00 | Outperform → Underperform | BMO Capital Markets |
12/1/2023 | $28.00 → $40.00 | Sector Perform → Outperform | RBC Capital Mkts |
6/22/2023 | $41.00 → $37.00 | Buy → Neutral | BofA Securities |
1/24/2023 | $31.00 → $43.00 | Neutral → Buy | UBS |
UBS analyst Joshua Spector upgrades Chemours (NYSE:CC) from Neutral to Buy and raises the price target from $28 to $30.
Mr. Satterthwaite Brings Over 30 Years of Global Power Generation Experience to Amprius Technologies Amprius Technologies, Inc. ("Amprius" or the "Company") (NYSE:AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, has appointed Livingston "Tony" Satterthwaite as an independent director on its Board of Directors (the "Board"), effective August 13, 2024. Mr. Satterthwaite will also be joining the Board's Compensation Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240814317462/en/Amprius Appoints Transportation Industry Veteran Tony Satterthwaite to Board of Directors (Photo: Busi
The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Livingston "Tony" Satterthwaite to its Board of Directors, effective June 12. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240613653963/en/Tony Satterthwaite named to Chemours' Board of Directors (Photo: Business Wire) "I'm pleased to welcome Tony as the newest member of Chemours' Board of Directors," said Dawn Farrell, Chair of the Board of Chemours. "Tony brings extensive leadership and board expe
The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Shane Hostetter as Chief Financial Officer (CFO) effective July 1, 2024. As CFO, Shane will lead Finance, Investor Relations, Corporate Development, Strategy, and Enterprise Risk Management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240605314740/en/Shane Hostetter, Chief Financial Officer (Photo: Business Wire) "Shane is a welcome addition to the Chemours team. With over 20 years' experience in a
4 - Chemours Co (0001627223) (Issuer)
3 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
The Chemours Company ("Chemours") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the third quarter of 2024. The dividend will be paid on September 13, 2024 to stockholders of record as of the close of business on August 15, 2024. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. We deliver customized solutions with a
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its second quarter 2024 financial results after market close on Thursday, August 1, 2024. The Company expects to hold its conference call to discuss its second quarter 2024 financial results at 8:00 a.m. Eastern Daylight Time on Friday, August 2, 2024. The call is open to the public and can be accessed via the below webcast information. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (N
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the second quarter of 2024. The dividend will be paid on June 14, 2024 to stockholders of record as of the close of business on May 15, 2024. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. We deliver customized solut
The fully integrable aftermarket approach will make it easy and cost effective for older vehicles to transition to climate-friendly Opteon™ YF (R-1234yf) The Chemours Company (Chemours) (NYSE:CC), a global leader in delivering innovative performance chemistry, today announced the development of a low global warming potential (GWP) refrigerant retrofit approach for the automotive aftermarket to support the global phasedown of higher GWP hydrofluorocarbon (HFC) refrigerants. The technical approach developed will provide vehicle owners—and their service technicians—with a simple retrofit procedure to safely and cost effectively replace the legacy R-134a refrigerant in their existing vehicle w
Mr. Satterthwaite Brings Over 30 Years of Global Power Generation Experience to Amprius Technologies Amprius Technologies, Inc. ("Amprius" or the "Company") (NYSE:AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, has appointed Livingston "Tony" Satterthwaite as an independent director on its Board of Directors (the "Board"), effective August 13, 2024. Mr. Satterthwaite will also be joining the Board's Compensation Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240814317462/en/Amprius Appoints Transportation Industry Veteran Tony Satterthwaite to Board of Directors (Photo: Busi
The facility will enable more sustainable, cost-effective, and high-performing EV batteries The Chemours Company (Chemours) (NYSE:CC), a global leader in delivering innovative performance chemistry, today announced the opening of the Chemours Battery Innovation Center (CBIC), a first-in-its-class laboratory facility located at the Chemours Discovery Hub in Newark, Delaware. A multi-million-dollar investment, the CBIC supports the testing and scaling of next generation battery technologies, to enable more sustainable, cost-effective, energy-efficient, and high-performing batteries for hybrid and electric vehicles (EVs). This press release features multimedia. View the full release here: h
8-K - Chemours Co (0001627223) (Filer)
10-Q - Chemours Co (0001627223) (Filer)
8-K - Chemours Co (0001627223) (Filer)
UBS upgraded Chemours from Neutral to Buy and set a new price target of $30.00 from $28.00 previously
Mizuho initiated coverage of Chemours with a rating of Neutral and set a new price target of $25.00
BMO Capital Markets upgraded Chemours from Underperform to Outperform and set a new price target of $34.00 from $19.00 previously
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)